Centre Muraz News Today

The final results of a landmark study published in The Lancet Infectious Diseases confirm that the benefits of combining the RTS,S/AS01E (RTS,S) malaria vaccine with antimalarial drugs in settings of highly seasonal malaria transmission continue over five years. The vaccine-drug combination reduced clinical malaria episodes, including cases of severe malaria, and deaths from malaria in young children by nearly two-thirds compared with either RTS,S vaccination or seasonal malaria chemoprevention ...

In a sub-study nested under the MISAME-III trial, an individually randomised controlled efficacy trial in rural Burkina Faso, Carl Lachat and colleagues investigate the effect of prenatal micronutrient-fortified balanced energy-protein supplementation on body composition of mothers and their newborns.

​​World Malaria Day: Invest, innovate, implement  ​Maternal Immunisation: Prevent, protect, immunise  ​Vaccinating women in pregnancy has emerged as a promising tool to protect women against infectious diseases and tackle infant morbidity and mortality worldwide. LSHTM Vaccine Centre World Immunisation Week activities will showcase the development of new maternal vaccines and provide the opportunity to discuss other vaccines with potential positive health outcomes.​ 

Carl Lachat and colleagues report a a 2×2 factorial individually randomized controlled trial conducted in rural Burkina Faso which investigates the impact of fortified balanced energy-protein supplementation during pregnancy and lactation on infant growth.

Brenda de Kok and colleagues investigate the efficacy of fortified BEP supplementation during pregnancy to improve birth outcomes, as compared to iron-folic acid (IFA) tablets, among pregnant women in rural Burkina Faso.

Brenda de Kok and colleagues investigate the efficacy of fortified BEP supplementation during pregnancy to improve birth outcomes, as compared to iron-folic acid (IFA) tablets, among pregnant women in rural Burkina Faso.

Zacchaeus Anywaine and co-workers study safety and immunogenicity of an Ebola vaccine among children and adolescents across four African countries.

Johnson & Johnson Joins World Health Organization in Efforts to Prevent Spread of Ebola in West Africa News provided by Share this article Up to 200,000 Johnson & Johnson Ebola vaccine regimens will be made available as part of a WHO early access clinical program now underway in Sierra Leone Companys Ebola vaccine regimen also receives Prequalification from the WHO The Johnson & Johnson vaccine regimen is designed to be used proactively to induce immunity against Ebola in adults and children N...

8 January 2021 by: Adam D. Cohen A research team based in the U.S. and Burkina Faso received last year’s Newcomb Cleveland Prize. | Neil Orman/AAAS Since 2010, the global number of deaths from malaria has decreased by 28%, largely due to the application of DDT, pyrethroids, and other insecticides to bed nets and living spaces. Still, a child dies of malaria every two minutes, and with mosquito populations becoming increasingly resistant to insecticides, vulnerable communities are in urgent ne...